Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases.

Pathak, Ranjan; Katel, Anjan; Massarelli, Erminia; Villaflor, Victoria M; Sun, Virginia; Salgia, Ravi

Pathak, Ranjan; Katel, Anjan; Massarelli, Erminia; Villaflor, Victoria M; Sun, Virginia; Salgia, Ravi.

Afiliação

Pathak R; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, California, USA.
Katel A; Department of Medicine, Kathmandu University School of Medical Sciences, Dhulikhel, Nepal.
Massarelli E; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, California, USA.
Villaflor VM; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, California, USA.
Sun V; Department of Population Science, City of Hope, Duarte, California, USA.
Salgia R; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, California, USA.

Oncologist ; 26(12): 1052-1061, 2021 12.

Article em En | MEDLINE | ID: mdl-34378270

Assuntos

Miastenia Gravis; Miocardite; Miosite; Idoso; Humanos; Inibidores de Checkpoint Imunológico; Miastenia Gravis/tratamento farmacológico; Miocardite/induzido quimicamente; Miosite/induzido quimicamente

Palavras-chave

Immune checkpoint inhibitor; Immune checkpoint inhibitors; Immune-related adverse events; Induced myocarditis; Myasthenia gravis; Myocarditis; Myositis; Overlap syndrome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Aged / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google